Advokatfirman Lindahl KB houses a ‘highly skilled’ team which is well placed to handle the full spectrum of work involving strategic partnerships and collaboration agreements. In the Uppsala office, practice head Hugo Norlén is noted for his extensive experience in assisting with tech transfers and R&D collaborations. Key figures within the team include Miranda Wink and Mikael Smedeby, with Smedeby particularly recognised for his longstanding expertise in M&A and corporate issues within the life sciences sector.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
‘Personlised service from dedicated team. The team has broad competence in many areas.’
‘Personal contact. Very quick to respond. Quickly tailors their services depending on your need.’
‘The team is highly skilled in the life sciences sector. They understand to a better degree how a typical financing takes place in small companies and how financial rounds can be planned and structured. They also have great in depth knowledge of the types of collaborations that are required and the nature of the agreements with such partners.’
‘Hugo Norlén has shown skill and enthusiasm to support us in our work. A person to mention is Isabella Mellberg. ’
‘Good insights and understanding of the complexities of our industry.’
‘Dedicated and service minded. Available when needed.’
‘Breadth of experience, focus on the industry, practical business approach, highly responsive, pleasure to work with.’
‘I work with many Lindahl partners and associates on different matters -- principally Hugo Norlén and Mikael Smedeby. All standouts.’
Key clients
- Affibody AB
- Amferia AB
- AMRA Medical AB
- BioArctic AB (publ)
- BioLamina AB
- Dilafor AB
- Egetis Therapeutics AB (publ)
- Intrance Medical Systems Inc
- Medivir AB (publ)
- Miris AB
Work highlights
- Advised Navinci Diagnostic on forging a strategic partnership with Leica Biosystems, enabling the first fully automated In Situ Proximity Ligation Assays (isPLA), paving the way for cutting-edge advancements in cancer diagnostics.
- Advised Amferia on an exclusive distribution partnership agreement with Swiss animal health leader Biokema SA to commercialise Amferia’s proprietary wound care technology for Animal Health in Switzerland.
- Advised the sellers of Abboxia AB on their strategic merger with FrostPharma AB.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Hugo Norlén
Other key lawyers
Miranda Wink; Mikael Smedeby; Isabella Mellberg